Missed opportunities to screen for Barrett's esophagus in the primary care setting of a large health system

被引:4
作者
Stewart, Molly [1 ,2 ]
Menon, Alisha [1 ]
Akbar, Usman [1 ,2 ]
Garg, Shashank [3 ]
Jang, Hye Jeong [1 ,2 ]
Trindade, Arvind J. [1 ,2 ,4 ]
机构
[1] Long Isl Jewish Med Ctr, Zucker Sch Med Hofstra Northwell, New Hyde Pk, NY 11040 USA
[2] Northwell Hlth, Inst Hlth Innovat & Outcomes Res, Feinstein Inst Med Res, Manhasset, NY USA
[3] Arkansas Gastroenterol, North Little Rock, AR USA
[4] Long Isl Jewish Med Ctr, 270-05 76th Ave, New Hyde Pk, NY 11040 USA
关键词
RADIOFREQUENCY ABLATION; SURVEILLANCE; MANAGEMENT;
D O I
10.1016/j.gie.2023.03.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: The rate of esophageal adenocarcinoma (EAC) is rising. This is partly due to the lack of identification of Barrett's esophagus (BE), the main risk factor for EAC. Identifying neoplastic BE can allow for endoscopic therapy to prevent EAC. Our aim was to determine how many patients eligible for screening are actually being screened for BE in the primary care setting of a large health system. Methods: A digital search algorithm was constructed using the established gastroenterology guidelines and the Kunzmann model for screening for BE. The algorithm was then applied to the electronic medical record of all patients seen in the primary care setting of the health system. A manual review of charts of the identified patients was performed to confirm the high-risk status and determine if screening occurred. Results: Of 936,371 primary care charts analyzed by the algorithm, 3535 patients (.4%) were determined to be high-risk for BE. Of these 3535 patients, only 1077 (30%) were screened for BE in clinical practice with endoscopy. The algorithm identified 2458 (70%) additional high-risk patients. Of the patients screened in clinical practice, 105 (10%) were found to have BE (10% with neoplasia). Conclusions: Numerous screening opportunities for BE are missed in the primary care setting of a large health system. Collaboration between gastroenterology and primary care services is needed to improve the screening rate. (Gastrointest Endosc 2023;98:162-9.)
引用
收藏
页码:162 / 169
页数:8
相关论文
共 20 条
[1]   Cost-Effectiveness of Endoscopic Screening Followed by Surveillance for Barrett's Esophagus: A Review [J].
Barbiere, Josephine M. ;
Lyratzopoulos, Georgios .
GASTROENTEROLOGY, 2009, 137 (06) :1869-1876
[2]   Low Prevalence of Endoscopic Screening for Barrett's Esophagus in a Screening-Eligible Primary Care Population [J].
Eluri, Swathi ;
Reddy, Sumana ;
Ketchem, Corey C. ;
Tappata, Manaswita ;
Nettles, Hanna G. ;
Watts, Ariel E. ;
Cotton, Cary C. ;
Dellon, Evan S. ;
Shaheen, Nicholas J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (11) :1764-1771
[3]  
Fitzgerald RC, 2020, LANCET, V396, P333, DOI 10.1016/S0140-6736(20)31099-0
[4]  
Glasheen WP, 2019, AM HEALTH DRUG BENEF, V12, P188
[5]   Accurate Nonendoscopic Detection of Barrett's Esophagus by Methylated DNA Markers: A Multisite Case Control Study [J].
Iyer, Prasad G. ;
Taylor, William R. ;
Johnson, Michele L. ;
Lansing, Ramona L. ;
Maixner, Kristyn A. ;
Hemminger, Lois L. ;
Cayer, Frances K. ;
Yab, Tracy C. ;
Devens, Mary E. ;
Slettedahl, Seth W. ;
Broderick, Brendan T. ;
Mahoney, Douglas W. ;
McGlinch, Maria C. ;
Berger, Calise K. ;
Foote, Patrick H. ;
Giakomopoulos, Maria ;
Allawi, Hatim ;
Smyrk, Thomas C. ;
Wang, Kenneth K. ;
Katzka, David A. ;
Wolfsen, Herbert C. ;
Burke, James A. ;
Ahlquist, David A. ;
Kisiel, John B. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (08) :1201-1209
[6]   Early-Onset Esophageal Adenocarcinoma Presents With Advanced-Stage Disease But Has Improved Survival Compared With Older Individuals [J].
Kolb, Jennifer M. ;
Han, Samuel ;
Scott, Frank I. ;
Murphy, Caitlin C. ;
Hosokawa, Patrick ;
Wani, Sachin .
GASTROENTEROLOGY, 2020, 159 (06)
[7]   External validation of a model to determine risk of progression of Barrett's oesophagus to neoplasia [J].
Kunzmann, Andrew T. ;
Thrift, Aaron P. ;
Johnston, Brian T. ;
McManus, Damian T. ;
Gavin, Anna T. ;
Turkington, Richard C. ;
Coleman, Helen G. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (10) :1274-1281
[8]   Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma [J].
Kunzmann, Andrew T. ;
Thrift, Aaron P. ;
Cardwell, Chris R. ;
Lagergren, Jesper ;
Xie, Shaohua ;
Johnston, Brian T. ;
Anderson, Lesley A. ;
Busby, John ;
McMenamin, Una C. ;
Spence, Andrew D. ;
Coleman, Helen G. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (08) :1229-+
[9]   Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus [J].
Moinova, Helen R. ;
LaFramboise, Thomas ;
Lutterbaugh, James D. ;
Chandar, Apoorva Krishna ;
Dumot, John ;
Faulx, Ashley ;
Brock, Wendy ;
Cabrera, Omar De la Cruz ;
Guda, Kishore ;
Barnholtz-Sloan, Jill S. ;
Iyer, Prasad G. ;
Canto, Marcia I. ;
Wang, Jean S. ;
Shaheen, Nicholas J. ;
Thota, Prashanti N. ;
Willis, Joseph E. ;
Chak, Amitabh ;
Markowitz, Sanford D. .
SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (424)
[10]   Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia A Randomized Clinical Trial [J].
Phoa, K. Nadine ;
van Vilsteren, Frederike G. I. ;
Weusten, Bas L. A. M. ;
Bisschops, Raf ;
Schoon, Erik J. ;
Ragunath, Krish ;
Fullarton, Grant ;
Di Pietro, Massimiliano ;
Ravi, Narayanasamy ;
Visser, Mike ;
Offerhaus, G. Johan ;
Seldenrijk, Cees A. ;
Meijer, Sybren L. ;
ten Kate, Fiebo J. W. ;
Tijssen, Jan G. P. ;
Bergman, Jacques J. G. H. M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (12) :1209-1217